[1]
D. Meske, PhD, E. A. Kopecky, PhD, S. Passik, PhD, and M. J. Shram, PhD, “Evaluation of the oral human abuse potential of Oxycodone DETERx® formulation (Xtampza® ER)”, J of Opioid Management, vol. 14, no. 5, pp. 359–372, Sep. 2018.